Camargo Pharmaceutical Services to acquire Canada-based InSymbiosis

Date: 2019-06-15   Author: Pankaj Singh  Category: #news

Camargo Pharmaceutical Services to acquire Canada-based InSymbiosis

Camargo Pharmaceutical Services, a leading drug development and commercialization service provider recently announced that it plans to acquire InSymbiosis, a Canada-based drug developer that enables biopharmaceutical companies to outsource research & development, cite sources.

The announcement came on the heels of an announcement made earlier this year by Camargo Pharmaceutical to expand its capabilities & global presence through acquisitions.

For the record, based in Montreal, Canada, InSymbiosis is managed by ex-pharma and contract research organization drug development executives and scientists. The company’s team includes financial and investment experts, a multidisciplinary drug development group and a competent project management team.

Dean Wenham, CEO, InSymbiosis was reported to say that the company started with a vision to build a mutual relationship across the healthcare landscape for pharmaceutical development. In partnership with Camargo, the synergy aims to deliver optimized development programs to clients and advance relationships across healthcare segment, Wenham added.

For the record, Camargo Pharmaceutical Services was founded in 2003 and is a global development & commercialization partner to large and small pharmaceutical companies. The company is known for its ability to provide life-changing therapies to clients, faster and more cost-effectively.

The company is established as a recognized expert & industry leader in designing complex, customized development strategies and focuses on client’s success. The client-base and global reach of Camargo extends to over more than 25 countries.

Dan Duffy, CEO, Camargo Pharmaceuticals was reportedly quoted saying that with the acquisition, the company will strengthen its ability to reach milestones & connect patients to life-changing therapies. InSymbiosis enables clients to optimize their clinical and non-clinical programs and provides excellent results.

Camargo Pharmaceuticals is better positioned in partnership with Insymbiosis to strengthen its efforts to deliver an industry-leading integrated drug development solution for the biotech and global pharma market, Duffy added.

Source credits: https://www.prnewswire.com/news-releases/camargo-pharmaceutical-services-enhances-drug-development-services-through-acquisition-of-montreal-based-insymbiosis-300866579.html



About Author


Pankaj Singh linkdin-boxtwitter

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

Post Recommendents

Glucosinolates Market Valued at USD 140 million in 2018 | Trends, Competitive Landscape, Geographical Overview

Author: Rahul Varpe

DecResearch Inc. published a comprehensive study on the Glucosinolates market. The report cover the top trends in the industry, key players, major segments, geographical analysis and some of other parameters that support to drive the business into...


Industrial Margarine Market Segmentation Analysis, Competitive Outlook, Growth Factors and Forecast till 2026

Author: Rahul Varpe

DecResearch Inc. published a comprehensive study on the Industrial Margarine market. The report cover the top trends in the industry, key players, major segments, geographical analysis and some of other parameters that support to drive the busines...


Grapeseed Oil Market Valued at USD 410 million in 2018 | Trends, Competitive Landscape, Geographical Overview

Author: Rahul Varpe

DecResearch Inc. published a comprehensive study on the Grapeseed Oil market. The report cover the top trends in the industry, key players, major segments, geographical analysis and some of other parameters that support to drive the business into ...